A 62-year-old woman with Lynch syndrome and advanced rectal cancer faced multiple tumors and a poor prognosis. Through targeted chemotherapy, surgery, and immunotherapy, she is now disease-free after nearly two years
The landscape of non-small cell lung cancer (NSCLC) treatment has dramatically evolved with the identification of specific genetic alterations that drive tumor growth. These molecular biomarkers have enabled the development of targeted therapies that significantly improve patient outcomes compared to traditional chemotherapy. This report provides a comprehensive overview of established and emerging biomarkers in NSCLC
Your Guide to Biomarkers and Associated Therapies in NSCLC Read More »
In September 2014, a persistent cough led to a surprising diagnosis of stage III non-small cell lung cancer. This inspiring story shows how expert care at MD Anderson and cutting-edge proton therapy helped one patient become cancer-free after five years.
From Cough to Cancer-Free: How Advanced Treatment at MD Anderson Saved a Life Read More »
This comprehensive guide explores the key differences between these approaches and addresses concerns about long-term survival for stage 4 cancer patients receiving palliative care.
Over the past 45 years, breast cancer treatment has undergone remarkable transformation, resulting in a substantial 35% reduction in breast cancer mortality in the United States between 1984 and 2014. This progress represents countless stories of innovation, persistence, and scientific breakthrough. Yet despite these advances, significant challenges remain for patients and their caregivers. This article explores
The Next Frontier in Breast Cancer Treatment (As of 2025) Read More »
Cancer prognosis is a complex topic that patients and caregivers often struggle to interpret correctly. When faced with a cancer diagnosis, many turn to the internet for information about survival and treatment outcomes, but this can lead to misunderstandings and unnecessary anxiety. This blog post aims to clarify common misconceptions about cancer prognosis, highlight issues with online prognosis data, provide guidance on understanding prognostic information more accurately, and share current survival statistics for common cancer types.
Understanding Cancer Prognosis: Beyond Five-Year Survival Rates Read More »
Lung cancer treatment has undergone a revolution over the past two decades, transitioning from one-size-fits-all chemotherapy to highly personalized approaches such as targeted therapies and immunotherapy. These advancements have significantly improved survival rates and quality of life for patients. However, challenges like drug resistance, limited biomarkers, and toxicity remain obstacles. Looking ahead, the field is poised for further
The Next Big Things in Lung Cancer Treatment (As of 2025) Read More »
Colorectal cancer (CRC) is one of the most preventable cancers, especially when detected early. Screening is a powerful tool that helps identify cancer or precancerous polyps before symptoms appear, giving patients and caregivers a fighting chance to stop the disease in its tracks. While colonoscopy has long been considered the gold standard for CRC screening, non-invasive options like Cologuard and its enhanced version, Cologuard Plus, are gaining attention for their convenience and effectiveness. In this blog post, we’ll explore how these tests work, their accuracy, limitations, and whether they can replace traditional screening methods like colonoscopy or older stool tests such as FOBT.
Cologuard and Cologuard Plus: A Patient-Friendly Guide to Colon Cancer Screening Read More »
A 42-year-old woman was diagnosed with HER2-positive metastatic breast cancer in 2010. Through targeted therapy, chemotherapy, radiation, and surgery, she achieved a complete pathological response and remains disease-free over a decade later.
Beating the Odds: A HER2-Positive Breast Cancer Survivor’s Story Read More »
A 51-year-old postmenopausal woman was diagnosed with HER2-positive metastatic breast cancer. Through targeted therapy and chemotherapy, she achieved a complete pathological response, offering hope for others facing similar diagnoses.
From Diagnosis to Remission: A HER2-Positive Breast Cancer Survivor’s Journey Read More »
